BMY

Bristol-Myers Squibb Co.
Data: 2026-08-21

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Quick Stats
Aug 21, 2026

37.0

AI Score

SELL

0.67

Volume Ratio

TBA

Next Earnings

22

+ve Days (30d)

8

-ve Days (30d)

BMY Stock Summary

Last updated Aug 21, 2026

BMY is currently trading at $67.01, positioned above its 200-day moving average of $57.13, indicating a long-term uptrend. The stock has a 52-week range of $42.52 to $68.64.

Technical Analysis: The 50-day moving average stands at $60.57, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 62.711, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.026, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BMY at 37.0/100 with a SELL recommendation.

BMY (Bristol-Myers Squibb Co.) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 62.711
CMF (20) 0.026
ROC (10) 3.538
ADX (14) 43.861
Indicator Value
MACD (12,26,9) 1.521
AROONOSC (14) 35.714
WILLAMS %R (14) -28.901
MFI (14) 45.249
BMY Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BMY Price vs Max Options Open Interest
BMY Max Change In Options Open Interest

BMY Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BMY Daily Out of Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BMY Daily In the Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BMY Most Active Options by Volume(near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Bristol-Myers Squibb Co. is above both the 50 Day and 200 Day SMA which is considered Bullish.

BMY Moving Averages Analysis

Bristol-Myers Squibb Co. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 21, 2026

Bristol-Myers Squibb Co. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 21, 2026

BMY (Bristol-Myers Squibb Co.) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 65.14
20 64.73
30 63.21
50 60.57
100 59.19
200 57.13

BMY Fundamental Analysis

P/E (Forward) 9.7943
P/E (Trailing) 14.4207
Market Cap ($) 133.7 billion
Earnings/Share ($) 4.54
Net Profit Margin (%) 0.1887
Dividend/Share ($) 2.51
EPS Estimate Current Year ($) 6.9491
EPS Estimate Next Year ($) 6.558
WallStreet Target Price ($) 66.21
Most Recent Quarter